HLA‐A3 increases and HLA‐DR1 decreases the risk of acute graft‐versus‐host disease after HLA‐matched sibling bone marrow transplantation for chronic myelogenous leukaemia
Richard E. Clark(University of Liverpool), J. Alejandro Madrigal(Anthony Nolan), David Nachbaur(Innsbruck Medical University), Gabriele Kropshofer(Innsbruck Medical University), D Niederwieser(University Hospital of Basel), Jane Apperley(Hammersmith Hospital), A Gratwohl(University of St.Gallen), Jo Hermans(Leiden University)
Cited by 23
Related Papers
Micrometastases and Survival in Stage II Colorectal Cancer
|New England Journal of Medicine|1998|601
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
|Blood|2010|485
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
|Leukemia|2016|473
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450